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Abstract Fibrous dysplasia (FD) is a rare bone disorder in
which normal bone is replaced by fibrous tissue resulting in
pain, deformities, pathological fractures or asymptomatic
disease. Illness perceptions are patients’ cognitions and
emotions about their illness and its treatment, which may
impact on Quality of Life (QoL). Here, we explore illness
perceptions in patients with FD compared to other disor-
ders, identify factors associated with illness perceptions
and evaluate their relationship with QoL. Ninety-seven out
of 138 eligible patients from the LUMC FD cohort com-
pleted the Illness Perception Questionnaire-Revised (IPQ-
R) and the Short Form-36 (SF-36). Age, Gender, Skeletal
Burden Score (SBS), FGF-23 levels, type of FD and SF-36
scores were analysed for an association with illness per-
ceptions. We observed significant (p\ 0.01) differences in
patients’ illness perceptions between FD subtypes in the
domains: identity, timeline acute/chronic and conse-
quences. Patients with craniofacial FD reported to perceive
more consequences (p = 0.022). High SBS was associated
with perceiving more negative consequences and
attributing the cause of FD to psychological factors
(p\ 0.01), and high FGF-23 levels with attributing more
symptoms to the disease and perceiving more conse-
quences (p\ 0.01). The IPQ-R domain identity, timeline
acute/chronic, timeline cyclical, consequences, emotional
representations and treatment control were significantly
associated with impairments in QoL. Illness perceptions in
patients with FD relate to QoL, differ from those in patients
with other disorders, and are associated with disease
severity. Identifying and addressing maladaptive illness
perceptions may improve quality of life in patients with
FD.
Keywords Fibrous dysplasia  McCune–Albright
syndrome  Illness perceptions  Quality of Life  Self-
management
Introduction
Fibrous dysplasia (FD) is a rare bone disorder that is
caused by a missense mutation of the GNAS gene, leading
to improper function of the alpha subunit of the hetero-
trimeric G protein (Gsa) that ultimately results in a local
disorder of bone formation [1]. This heterogeneous disease
can present with a wide spectrum of clinical manifestations
from a lesion in a single bone (monostotic FD), in multiple
bones (polyostotic FD) with or without endocrinopathies
such as precocious puberty, or growth hormone excess in
the McCune–Albright syndrome (MAS). FD lesions may
be associated with bone pain, skeletal deformities and
pathological fractures, although they may also be asymp-
tomatic. Quality of Life (QoL) has been reported to be
more severely affected in patients with the more severe
types of FD. Determinants of severe disease including a
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High Skeletal Burden Score (SBS) and increased bone
turnover markers (BTM), have been identified as deter-
minants of impaired QoL [2, 3]. Other factors than those
directly related to the disease which also influence QoL are
‘illness perceptions’: the thoughts and emotions that a
patient has concerning his or her disease and its treatment
[4]. These perceptions originate from various sources, such
as information from social circles the patient moves in,
information from health care providers, experiencing other
or previous illnesses, information from other patients with
the same disorder, or general or social media [5, 6]. The
common-sense model (CSM) of self-regulation, which
outlines illness perceptions and their relations with
sociodemographic and clinical characteristics, and coping
and outcome (QOL), aims at examining cognitive and
emotional representations to illness [7, 8]. The CSM is
based on the premise that an individual solves a problem
(i.e., a perceived threat to health, an illness) in an active
manner by trying to make sense of the threat to his or her
health or illness. These perceptions are clustered around
five components, forming the illness perceptions that
determine the patients’ coping behavior. These cognitive
components are (1) identity the label that the individual
uses to describe the condition and its symptoms, (2) cause
ideas that the individual has about the cause(s) of the
condition, (3) timeline expectations of the individual about
the duration of the condition, (4) consequences effects of
the disease on the physical, psychological and social
functioning of the individual, and (5) cure/control the
extent to which the individual perceives that the condition
is amenable to cure and/or control [9].
The Illness Perception Questionnaire-Revised measures
these illness perceptions in patients with different diseases
[10, 11]. Since illness perceptions have been shown to
influence QoL, it is important to characterize these per-
ceptions in patients with FD [12]. In this study, we explore
illness perceptions in patients with FD, as an extension of a
previous study evaluating QoL in the same population [3].
We further explore the relationship between illness per-
ceptions and QoL in patients with FD and also aim at




All patients aged 15 years or older and who had been seen
at the outpatient clinic of the LUMC in the previous
3 years were asked to take part in the study. Patients were
invited by mail to participate in the study, which implied
filling in a number of questionnaires, including the Illness
Perception Questionnaire-Revised (IPQ-R) and the Short
Form 36 (SF-36), a questionnaire assessing functional
status, as previously described [3]. Patients who did not
respond were approached by telephone with a maximum of
two attempts.
Clinical and Sociodemographic Characteristics
Patient data were retrieved from electronic medical
records. Level of education was categorized using the
International Standard Classification of Education (ISCED)
[3]. Low level of education was defined as a primary to
lower secondary education; medium level of education was
defined as an upper secondary to post-secondary non-ter-
tiary education; and high level of education was defined as
the first and second stage of tertiary education. Data on age,
gender, age at diagnosis, type of FD, fractures and
extraskeletal manifestations (e.g., precocious puberty, GH-
excess, café-au-lait patches) were collected. Data on
medical or surgical treatment were also retrieved from
medical records. Fibroblast growth factor 23 (FGF-23) was
obtained from serum measurements within 2 months of
completing the questionnaires [13]. Skeletal burden scores
(SBS) were blindly assessed by two authors (BCJM and
NMA-D) for all patients in whom a 99Technetium skeletal
scintigraphy was available [14].
Fig. 1 Flowchart of patient inclusion and participation rate
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Illness Perception Questionnaire-Revised (IPQ-R)
The IPQ-R questionnaire was designed to evaluate cogni-
tive and emotional representations of illness in patients
with chronic or acute conditions [10, 11]. The question-
naire consists of three different parts: illness identity, ill-
ness perception and causal attributions.
Identity
This part of the questionnaire is built-up of 14 commonly
occurring symptoms and of 13 commonly occurring
symptoms related to the disease under study, in this case
FD. Patients are asked if they have any of these 27
symptoms and whether they believe that their disease is the
cause of these symptoms. The score on the identity sub-
scale represents the degree to which patients relate com-
mon symptoms they suffer from to their disease [10, 15].
Illness Perceptions
The second part of the questionnaire is built-up of 38
statements concerning views on the illness under study as
evaluated on a five-point scale (strongly disagree to
strongly agree) that together are divided into seven sub-
scales, including:
1. Timeline acute/chronic Includes six questions that
assess the timeline of the disease. Do the patients
regard their illness as an acute/temporary condition, or
do they believe their condition to be more permanent?
2. Timeline cyclical Includes four questions that differ-
entiate between daily changes in symptoms of the
disease and constantly present symptoms.
3. Consequences Includes six questions on the effect and
consequences of the condition on patients’ daily lives.
4. Emotional representations Includes six questions that
aim at quantifying the emotional response (anxiety,
anger, depression, etc.) of a patient to his or her
condition.
5. Personal control The combined score of six questions
that represent the extent to which patients perceive
having control over their illness.
6. Treatment control Five questions about whether a
patient perceives the illness to be under control with
(current) treatment.
7. Illness coherence Five questions on the patients’
personal understanding of their disease.
Causal Mechanisms
This part covers any mechanisms that patients may believe
to be responsible for their disease and consists of 18
statements regarding perceived causes on a scale ranging
from strongly agree to strongly disagree. Using a principal
component analysis with varimax rotation, the causal items
are clustered into variables with shared variance [10, 16].
These variables represent the causes of their disease from
the patients’ perspective. Higher scores on the subscales
indicate stronger beliefs in those attributions causing the
disease.
Principal Component Analysis
The factor analysis generated four factors, accounting for
71% of the total variance. Two factors accounted for the
largest part if the variance: psychosocial attributions (ac-
counting for 30% of the variance) and environmental fac-
tors (accounting for 23% of the variance), with a
Cronbach’s a above the lower limit of 0.3 (0.937 and
0.865, respectively). Examples of the factor ‘psychosocial
attributions’ include that FD is caused by daily stress or by
a patients’ behavior; for the factor ‘environment’ that the
disease is caused by heredity or a history of poor medical
care. The other two factors, ‘accident’ and ‘chance’ were
excluded from further analysis because of a low Cron-
bach’s a.
Interpretation of the IPQ-R Outcomes
To put the outcomes of IPQ-R scores of FD patients in
perspective, we compared these with reference groups of
patients with acute pain [10], chronic pain [10], acrome-
galy [17] and fibromyalgia [6, 17, 18]. Data on reference
groups of patients with acute pain (less than 6 weeks) and
chronic pain (longer than 3 months) used in this study,
originated from the study used to develop the revised
version of the IPQ-R [10]. We also chose to compare the
illness perception outcomes of our patients with FD with
outcomes from a study on patients with acromegaly (47
male and 34 female), as patients with this disorder have
been shown to be self-conscious about their appearance,
leading to psychological distress, disruptions in everyday
life and eventually impairments in QoL [19]. Although
acromegaly is not characterised by facial asymmetry,
patients with acromegaly do share a number of similarities
with patients with craniofacial FD and MAS, such as
excessive GH production, chronic joint pain, and marked
facial deformities, which provided the rationale for
choosing patients with this disorder as reference group.
Lastly, we compared the scores in our set of patients with
those of a cohort of patients with fibromyalgia (FM) (47
female and four male), as this is also a chronic disease
associated with (multifocal) musculoskeletal pain.
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Identification of Associated Factors for Illness
Perceptions
IPQ-R domain scores were compared between the different
types of FD (monostotic/polyostotic/MAS) because of the
broad spectrum of clinical manifestations of FD between
these subtypes. Scores were also compared between
patients with and without craniofacial disease, as we
hypothesized that patients with craniofacial disease might
score worse on the emotional domains because these
patients may perceive to attract more negative attention as
a result of their visible craniofacial deformities [20].
Domain scores of the IPQ-R were evaluated for a pos-
sible relationship with two clinical parameters of disease
extent and severity, including SBS and serum levels of
FGF-23, to evaluate whether patients with more severe
disease have different illness perceptions compared to
those with milder forms of FD. We also assessed possible
relationships between subscales of the SF-36 and different
domains of the IPQ-R, for which the outcomes on the SF-
36 in a previous study into QoL in persons with FD were
used [3].
Statistical Analysis
Statistical analysis was performed using SPSS for Win-
dows, Version 23.0 (SPSS, Inc., Chicago, IL, USA).
Results are presented as mean (± SD) or as median (in-
termediate range) and in case of categorical data as a
percentage. Differences between FD subtypes (monostotic/
polyostotic/MAS) were compared using ANOVA, with
post hoc analysis undertaken where appropriate. Difference
between craniofacial and non-craniofacial FD was assessed
using the Student’s T test. The IPQ-R scores of our FD
cohort were compared with reference cohorts with the use
of the Student’s T test (with level of significance set at
p B 0.05). IPQ-R scores were checked for normal distri-
bution and correlated accordingly with one another using
either the Pearson’s Correlation Coefficient or the Spear-
man’s Rank Correlation Coefficient (with level of signifi-
cance set at p\ 0.01 to correct for multiple testing).
Possible associations were assessed between the IPQ-R
scores and the SF-36 scores (previously reported SF-36
outcomes in this cohort are included in supplementary
Table 1).
Results
Patient Characteristics (Table 1)
Out of a total of 138 eligible patients who were invited to
participate in the study, two patients refused to take part,
eight patients did not participate due to non-FD-related
comorbidities (e.g., colon cancer, multiple sclerosis,
osteosarcoma (n = 2), chondrosarcoma, severe rheumatoid
arthritis, cardiac failure and significant learning disability)
and 27 patients did not respond to our invitation. There
were no significant differences between responders and
non-responders except for gender; significantly more
women completed the questionnaires (p = 0.039).
Response rate was 70.3% with a total of 97 patients, 65%
women, completing the questionnaires. Median age at
diagnosis of FD was 29 years (range 1–68) and median age
at completion of the questionnaires was 46 years (range
16–80). Level of education was low in 10 patients, medium
in 24 patients, high in 46 patients and unknown in 17
patients. Sixty-two patients (64%) had monostotic FD, 26
(27%) had polyostotic FD, 9 (9%) had MAS and 5 (5%)
had intramuscular myxomas in the context of Mazabraud’s
syndrome. The craniofacial bones were affected in 23
patients (23%) and mean SBS was 8.68 (± 12.40 SD). SBS
(p\ 0.001), average FGF-23 (p = 0.002), a history of at
least one fracture (p = 0.001) and of surgical interventions
(p\ 0.001) significantly differed between FD subtypes
(monostotic/polyostotic/McCune–Albright syndrome) with
increasingly higher SBS, FGF-23 levels and fracture and
surgical intervention rates in the more severe subtypes.
Median duration of follow-up was 12 years (range
0–62 years).
Illness Perceptions in FD Patients Compared
to Reference Groups (Table 2)
Compared to patients with acute pain, patients with FD
were more aware of the chronicity of their disease
(p\ 0.001), perceived more fluctuations (p\ 0.001) and












Follow-up (years) 12 (0–62)
Data are median (range) or number and percentage
B. C. J. Majoor et al.: Illness Perceptions are Associated with Quality of Life in Patients…
123
had a better personal understanding of their disease
(p\ 0.001). However, patients with FD experienced less
personal control (p\ 0.001) and less treatment control
(p\ 0.001) of their illness.
Compared to patients with chronic pain, patients with
FD attributed less of their symptoms to their disease
(p\ 0.001) and perceived more chronicity (p\ 0.01) and
less consequences (p\ 0.001) of their illness, had a better
personal understanding of their disease (p\ 0.001) and
less emotional representations (p\ 0.001).
Compared to patients with fibromyalgia, patients with
FD attributed fewer symptoms to their disease (p\ 0.001),
perceived fewer fluctuations (p\ 0.001), perceived fewer
consequences (p\ 0.01) and perceived less personal con-
trol (p\ 0.01).
Compared to patients with acromegaly, patients with FD
perceived more chronicity (p\ 0.01) and more fluctua-
tions of their symptoms (p\ 0.001) and had less control
over their treatment (p\ 0.001). They also had worse
personal understanding of their disease (p\ 0.001) and
perceived more emotional representations (p\ 0.01).
Illness Perceptions in Different Subtypes of Fibrous
Dysplasia (Table 3)
There was a significant difference between subtypes of FD
for: identity (p = 0.006), timeline acute/chronic
(p = 0.002) and consequences (p\ 0.001). Patients with
MAS consistently demonstrated more negative illness
perceptions in these domains compared to patients with
polyostotic FD without endocrinopathies. Similarly,
patients with polyostotic FD scored higher in these
domains compared to patients with monostotic FD, illus-
trating that patients diagnosed with more severe subtypes
of FD more often attribute their symptoms to FD, regularly
experiencing their disease as chronic, reporting more
consequences of their illness. There were no significant
differences in other subscales of the IPQ-R. Patients with
craniofacial FD scored significantly higher in the conse-
quence domains (18.8 ± 5.7SD vs. 15.6 ± 5.6SD;
p = 0.022) but this difference disappeared after correction
for the presence of MAS. There were no significant dif-
ferences between patients with and without craniofacial
disease in other subscales of the IPQ-R.
Associated factors for Illness Perceptions (Table 4)
High skeletal burden scores as an indicator of severe dis-
ease were found to correlate with perceiving more conse-
quences (R = -0.35; p = 0.003) and with more
psychological attribution domains (R = 0.312; p = 0.010)
of the IPQ-R. High average serum concentrations of FGF-
23 correlated with attributing more complaints to FD
(identity) (R = -0.389; p = 0.004) and perceiving more
consequences of their illness (R = -0.37; p = 0.007).
Relationship Between Illness Perceptions and QoL
(Table 5)
Attributing more symptoms to the disease was associated
with perceiving more limitations in the domain’s physical
functioning (p\ 0.001), physical role (p\ 0.001), bodily











Identity 3.5 (3) 2.8 (2) 6.2 (3)b 5.5 (2)b 2.5 (2)
Timeline acute/chronic 25.1 (5) 13.4 (5)b 23.1 (4)a 25.4 (4) 22.9 (6)a
Timeline cyclical 12.1 (3) 9.4 (3)b 12.9 (4) 15.0 (3)b 10.1 (4)b
Consequences 16.5 (6) 14.2 (4) 23.5 (4)b 19.3 (4)a 16.9 (5)
Personal control 17.3 (4) 22.9 (4)b 18.4 (4) 19.5 (4)a 17.5 (5)
Treatment control 15.5 (4) 19.4 (3)b 14.2 (3) 15.7 (3) 18.1 (3)b
Illness coherence 15.9 (3) 9.3 (3)b 13.4 (5)b 15.9 (3) 17.5 (3)b
Emotional representations 14.7 (5) 16.1 (4) 19.8 (4)b 16.2 (5) 12.6 (4)a
Psychological attributions (score
range 8–29)
13.2 (6) NA NA NA NA
Environmental (risk) factors (score
range 7–23)
12.2 (5) NA NA NA NA
Data are mean (SD)
NA not applicable
ap\ 0.01 compared with patients with fibrous dysplasia
bp\ 0.001 compared with patients with fibrous dysplasia
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pain (p\ 0.001), general health (p\ 0.001), social func-
tioning (p\ 0.001) and mental health (p\ 0.001). A more
chronic experience of FD was associated with perceiving
more impairments in physical function (p = 0.005) and
more bodily pain (p\ 0.001). Experiencing symptoms of
FD more chronically throughout the day was associated
with more impairments in physical function (p = 0.005),
social function (p = 0.01) and more bodily pain
(p = 0.002). Both experiencing more consequences of FD
and having more emotional representations of FD were
associated with more impairments in all domains of the SF-
36. Lastly, perceiving less treatment control was associated
with more impairments in general health (p\ 0.001) and
vitality (p\ 0.001). There were no significant correlations
found for other IPQ-R dimensions.
Discussion
Our data indicate that illness perceptions significantly dif-
fer between patients with FD and patients with a number of
other conditions associated with acute or chronic pain.
Patients with FD report more negative illness perceptions
than patients with acromegaly, but more positive illness
perceptions compared to patients with fibromyalgia.
In comparison with the reference groups, personal and
treatment control were the most prevalent negative illness
perceptions in FD patients, indicating that these patients
experience very little control over the course and treatment
of their condition. This can partially be attributed to the
chronic character of FD, since chronicity of the disease was
perceived to be higher in patients with FD compared
patients with either acute or chronic pain and those with
acromegaly, possibly as a reflection of current limitations
in treating the disease. There is no cure for FD and current
treatment modalities indeed fail to provide a long-term
solution for the symptoms of FD, although surgical inter-
ventions or medical therapy are to some extent able to
decrease pain and improve function. A significant











Identity 2.8 (3)c 4.4 (4) 6.2 (6)a 4.6 (4) 3.2 (3)
Timeline acute/chronic 23.9 (5)b 27.4 (4)a 28.3 (2) 25.5 (5) 25.1 (5)
Timeline cyclical 11.7 (4) 13.3 (5) 13.3 (5) 12.2 (3) 12.2 (4)
Consequences 14.6 (6)b,c 19.0 (4)a 21.4 (6)a 18.8 (6)a 15.6 (6)a
Personal control 17.3 (4) 17.5 (4) 16.3 (4) 16.7 (4) 17.5 (4)
Treatment control 15.6 (4) 15.7 (3) 14.1 (4) 16.5 (4) 15.2 (3)
Illness coherence 15.7 (3) 16.3 (2) 16.3 (3) 15.5 (3) 16.0 (3)
Emotional representations 14.3 (6) 15.8 (4) 13.9 (4) 15.3 (5) 14.5 (5)
Psychological attributions (score range
8–29)
14.1 (6) 12.0 (5) 9.4 (3) 11.4 (5) 13.7 (6)
Environmental (risk) factors (score
range 7–23)
12.8 (5) 11.8 (5) 8.6 (3) 11.4 (5) 12.5 (5)
Data are mean (SD)
ap\ 0.05 compared monostotic
bp\ 0.05 compared polyostotic
cp\ 0.05 compared with McCune-Albright
Table 4 Associated factors for illness perceptions in fibrous
dysplasia
IPQ-R domain SBS FGF-23
SRCC Sig. SRCC Sig.
Identity -0.25 0.039 -0.389 0.004
Timeline (acute/chronic) -0.27 0.027 -0.03 0.822
Timeline (cyclical) -0.04 0.751 -0.14 0.310
Consequences -0.35 0.003 -0.37 0.007
Personal control 0.07 0.582 -0.06 0.650
Treatment control 0.06 0.625 -0.04 0.804
Illness coherence -0.19 0.115 -0.18 0.191
Emotional representations -0.05 0.716 -0.20 0.910
Psychological attributions 0.312 0.010 0.070 0.620
Environmental (risk) factors 0.268 0.027 0.199 0.158
Attributing factors for illness perceptions in fibrous dysplasia with
significance set at p = 0.01
SRCC Spearman’s rank correlation coefficient
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proportion of these patients need multiple surgical inter-
ventions or continuous use of anti-resorptive agents due to
persistent symptoms of continuous pain as well as recurrent
fractures [21–23]. Further development of effective medi-
cal treatments could help to increase the faith that patients
would have in their control over their disease. Developing
disease-specific self-management skills could possibly
boost personal control over the disease, for example with
appropriate mobilization aids or more specifically with
self-management training, aimed at exploring and changing
the illness perceptions and therefore coping strategies of
the individual patient [4, 24]. In a biopsychosocial
approach, this would mean that negative thinking about FD
should be identified early to initiate an intervention aiming
at better adaption to FD and more adaptive expectations
[9]. In FD, this could for example mean adaption of
unrealistic ideas about mobilizing or actively participating
in sports due to an increased fracture risk. Once identified,
a possible intervention to address these negative percep-
tions would be to stimulate patients to develop a personal
plan on mobilizing and participating in sports in a fashion
that minimizes the risk of fracturing a bone with fibrous
dysplasia. Developing a personal plan of action has pre-
viously been used to adequately address illness perceptions
in persons with other conditions [9, 25]. As a result of this
personal plan, these patients might increase their physical
activity and are likely to similarly increase their appreci-
ating of their QoL.
Data from this study also show that patients with the
more severe types of FD attribute a greater part of their
symptoms to their illness, experience their FD as more
chronic and are perceiving more consequences in their
daily life. These findings are in line with the more severely
impaired QoL in these severe subtypes and are further
underlined by the association of high SBS and serum levels
of FGF-23, both indicators of more severe disease, with
negative illness perceptions of the consequences of FD.
[3, 13, 14] Interestingly, several studies reporting on pain
deriving from bony lesions in patients with fibrous dys-
plasia fail to find an association between pain severity and
SBS, consistently describing a wide variation in pain
symptoms between patients with FD who are similarly
affected. [3, 26] However, our data show that increased
perception of bodily pain, as assessed by the SF-36 ques-
tionnaire, is associated with attributing more symptoms to
the disease, a more chronic experience of FD, experiencing
symptoms of FD more chronically throughout the day,
experiencing more consequences of FD and having more
emotional representations of FD. The precise pathogenic
mechanism underlying the development of pain in patients
with FD remains to date elusive [27]. Although following a
variable pattern across the wide clinical spectrum of FD,
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illness perceptions, with pain being probably an important
factor contributing to impairments in quality of life in these
patients.
As previously shown in patients with other (endocrino-
logical) disorders such as for example Cushing’s syndrome
and acromegaly, the current study demonstrates that neg-
ative illness perceptions are associated with impairments in
many QoL domains as assessed by the SF-36 questionnaire
[4, 17, 28]. This especially includes the illness perception
domains of identity, timeline, consequences and emotional
representations. It is, therefore, plausible that addressing
these perceptions might prove to be a useful tool in the
management of patients with FD. Current treatment
modalities are unable to fully control the symptoms of FD,
particularly in the more severe type of the disease. Psy-
chological support aiming at minimizing negative illness
perceptions may thus go a long way to improve QoL in the
long term in these patients. This is particularly important,
as there is no cure for the disease. Cognitive behavioral
therapy, self-management training or information on the
possible negative effects of FD applied at an early stage in
the course of the disease may, therefore, improve mal-
adaptive illness perceptions, probably eventually leading to
improved function and QoL in patients with FD [4, 7].
Our study has strengths as well as limitations. Despite
the fact that we were able to investigate both QoL and
illness perceptions in a relatively large cohort of patients
with FD, we appreciate that especially the group of MAS
patients, and therefore the significant differences found in
this group, are underpowered and should be interpreted
with care. This limitation is generally shared with all rare
and heterogeneous diseases and in future research this
could possibly be addressed by extending our levels of
collaboration between international centers in these types
of disorders. However, it is likely that the differences that
we found between the subtypes of FD will be even more
evident in stronger powered studies. In addition, we were
able to get a good representation of our cohort of FD
patients with a response rate of 70.3%. The other main
limitation of our study lies in its cross-sectional design,
with a single-time-point measurement of both illness per-
ceptions and QoL, precluding any statements about cause
and effect, therefore. It would be interesting to analyze the
course of illness perceptions and QoL over time and
especially the effect of self-management on the course of
FD. Despite these limitations, we believe that our current
data holds important leads for physicians involved in
medical care for patients with FD, in understanding the
impairments of FD in individual patients and the percep-
tions of these patients regarding their disease.
In conclusion, this first study on illness perceptions in
patients with FD demonstrates that illness perceptions are
affected throughout the wide spectrum of fibrous dysplasia
and that these perceptions are associated with impairments
in quality of life. Severity of disease as expressed by high
skeletal burden scores and increased serum levels of FGF-
23 were associated with these maladaptive illness percep-
tions. Altering unhelpful illness perceptions in these
patients may represent a promising tool in the management
of patients with FD, particularly in the more severely
affected patient by helping coping behavior and improving
quality of life in FD.
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